Showing results (181-190 of 192) with videos related to
Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|September 26, 2025
CXCR6+ CD127- Tr1 Cells Balance Immunity and Persistence in Plasmodium falciparum InfectionJason Nideffer, Florian Bach, Steven Strubbe, et al.The Journal of Clinical Investigation|May 5, 2026
CXCR6+CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infectionJason Nideffer, Florian Bach, Steven Strubbe, et al.The New England Journal of Medicine|January 31, 2009
Gene therapy for immunodeficiency due to adenosine deaminase deficiencyAlessandro Aiuti, Federica Cattaneo, Stefania Galimberti, et al.Science Immunology|April 25, 2025
Clone tracking through repeated malaria identifies high-fidelity memory CD4 T cell responsesJason Nideffer, Florian Bach, Felistas Nankya, et al.Science Immunology|May 2, 2025
Distinct type I and II interferon responses direct cortical and medullary thymic epithelial cell developmentAbdulvasey Mohammed, Wenqing Wang, Martin Arreola, et al.Nature Medicine|July 22, 2025
Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trialRajni Agarwal, Alice Bertaina, Charmaine Soco, et al.Science (New York, N.Y.)|July 13, 2013
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophyAlessandra Biffi, Eugenio Montini, Laura Lorioli, et al.Science (New York, N.Y.)|July 13, 2013
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndromeAlessandro Aiuti, Luca Biasco, Samantha Scaramuzza, et al.The Lancet. Haematology|April 15, 2019
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical studyFrancesca Ferrua, Maria Pia Cicalese, Stefania Galimberti, et al.Nature|July 12, 2018
Reprogramming human T cell function and specificity with non-viral genome targetingTheodore L Roth, Cristina Puig-Saus, Ruby Yu, et al.Pageof 20